The device was not received for evaluation; therefore no physical analysis of the device can be performed.The manufacturing batch record review confirmed that the device met all material, assembly and inspections.The patient information and event date were reported to be unknown.Product is expected to be returned.If there is any further relevant information provided, a follow-up medwatch report will be provided.
|
Device evaluation: the manufacturing batch record review confirmed that the device met all material, assembly and inspections.As received, the specimen consists of one each hydro gw std an 260-035 device; returned loaded within the dispenser assembly, within the opened, labeled mylar/tyvek packaging pouch and double-bagged within "zip-lock" style poly pouches.As received, the dispenser assembly does not present any residual moisture visible within the tubing lumen typical of flushing the dispenser with saline prior to use.After injecting the dispenser assembly with 12cc of room temperature (22 degrees) blood-bank saline, the specimen was easily removed from the dispenser and subjected to visual and tactile examination.The specimen coating appears visually and tactilely consistent when examined at 1x - 18 inches, unaided, wet.The specimen presents 3.3mm of the metallic core wire protruding through the polymer jacket at 0.47cm from the distal tip.The polymer jacket presents indications of elastic deformation in the vicinity of the core wire protrusion and a 0.92mm tear immediately distal of the core wire penetration.The tip shape is altered by the damage.Microscopically the specimen coating appears to be smooth and consistent.Except where noted, the specimen device appears visually and dimensionally correct.At this time it is not possible to assign a definitive root cause for the event as reported.Based on the information provided, handling and or procedural factors appear to have impacted on the event as reported.The event date and patient information were reported to be unknown.If there is any further relevant information received, a follow-up medwatch report will be filed.
|